In cases of heart failure, clinical guidelines only recommend use of brain natriuretic peptide (BNP) levels for confirmation of diagnosis. After analyzing data from a large US registry, Fonarow and co ...
June 18, 2009 (Washington, DC) — Changes in natriuretic-peptide levels over the first five days of hospitalization for acute decompensated heart failure (ADHF) significantly and independently predict ...
BNP test in the emergency department differentiates between CHF and lung disease in dyspnea patients
San Diego, CA A rapid BNP assay can help differentiate between cardiac and pulmonary causes of acute dyspnea in the emergency room, saving time, money, and lives. So say researchers who have now ...
Brain natriuretic peptides (BNPs) are released from cardiac myocytes in times of ventricular wall stress; their levels correlate with the severity of heart failure. The prognostic value of BNP levels ...
While B-type natriuretic peptide (BNP) levels remain high in patients with end-stage heart failure with cardiogenic shock, these levels lose their prognostic value in patients using ventricular assist ...
An assay measuring N-terminal pro-BNP, or NT-proBNP, is more sensitive to detect heart failure and used in many institutions. The levels of BNP and NT-proBNP are essentially the same in normal ...
Patients presenting shortness of breath on arrival at the emergency department (ED) can gain from improved diagnosis allowing physicians to distinguish congestive heart failure patients from those ...
B-type natriuretic peptide (BNP) as well as its N-terminal fragment (NT-proBNP) can provide useful diagnostic and prognostic information in patients with acute dyspnea and chronic heart failure.
A drug known to reduce mortality rate in patients with heart failure has now been found significantly effective when administered early in patients following an acute (ST elevated) myocardial ...
To the Editor: In their interesting study of the prognostic value of brain (B-type) natriuretic peptide in patients with acute coronary syndromes, de Lemos et al. (Oct. 4 issue) 1 did not thoroughly ...
Creative Diagnostics announced the launch of its new range of BNP and NT-proBNP antibodies for raw material and research applications. The natriuretic peptides, including proBNP (pro-brain natriuretic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback